The Lancet Rheumatology
@thelancetrheum.bsky.social
The #LancetRheumatology is a clinical #rheumatology journal publishing innovative & practice-changing research & opinion across all #rheumatic & #MSK disorders.
🌐 https://www.thelancet.com/journals/lanrhe/home
🌐 https://www.thelancet.com/journals/lanrhe/home
Our December issue is live!
Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
November 18, 2025 at 3:16 PM
Our December issue is live!
Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social
Free to read with registration on lancet.com
Free to read with registration on lancet.com
November 13, 2025 at 3:00 PM
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social
Free to read with registration on lancet.com
Free to read with registration on lancet.com
NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
November 6, 2025 at 3:42 PM
NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
October 31, 2025 at 9:55 AM
NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
🔥Hot off the press for #ACR25 🔥
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
October 29, 2025 at 12:50 PM
🔥Hot off the press for #ACR25 🔥
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
ILD risk prediction in routine care for rheumatoid arthritis
Linked Comment by Javier Narváez bit.ly/431cfTo
Linked Comment by Javier Narváez bit.ly/431cfTo
October 27, 2025 at 2:39 PM
ILD risk prediction in routine care for rheumatoid arthritis
Linked Comment by Javier Narváez bit.ly/431cfTo
Linked Comment by Javier Narváez bit.ly/431cfTo
NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social
October 27, 2025 at 2:38 PM
NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
October 24, 2025 at 3:47 PM
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
NEW—The Nobel celebrates tolerance
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
October 24, 2025 at 10:01 AM
NEW—The Nobel celebrates tolerance
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
October 23, 2025 at 8:40 AM
Our November issue is live!
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
October 21, 2025 at 4:39 PM
Our November issue is live!
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
October 20, 2025 at 10:36 AM
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
NEW REVIEW—Synovial immunopathology in psoriatic arthritis: cellular and molecular insights bit.ly/4pKi9Su #Medsky #Rheumsky
October 3, 2025 at 4:37 PM
NEW REVIEW—Synovial immunopathology in psoriatic arthritis: cellular and molecular insights bit.ly/4pKi9Su #Medsky #Rheumsky
Can AI be used to classify the focus score in Sjögren's disease?
Linked Comment by Tamandeep K Bharaj & Kathrine Skarstein
bit.ly/48dXWyl
Linked Comment by Tamandeep K Bharaj & Kathrine Skarstein
bit.ly/48dXWyl
September 30, 2025 at 1:30 PM
Can AI be used to classify the focus score in Sjögren's disease?
Linked Comment by Tamandeep K Bharaj & Kathrine Skarstein
bit.ly/48dXWyl
Linked Comment by Tamandeep K Bharaj & Kathrine Skarstein
bit.ly/48dXWyl
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
September 26, 2025 at 10:39 AM
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
Our October issue is live!
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
September 23, 2025 at 11:20 AM
Our October issue is live!
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social
September 17, 2025 at 3:27 PM
NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social
NEW—Unscientific vaccine policy endangers vulnerable patients
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
September 13, 2025 at 4:14 PM
NEW—Unscientific vaccine policy endangers vulnerable patients
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Modelling allopurinol-induced severe adverse cutaneous reactions
Linked Comment by @profbeckyg.bsky.social & Lisa K Stamp bit.ly/47JPK8N
Linked Comment by @profbeckyg.bsky.social & Lisa K Stamp bit.ly/47JPK8N
September 11, 2025 at 3:49 PM
Modelling allopurinol-induced severe adverse cutaneous reactions
Linked Comment by @profbeckyg.bsky.social & Lisa K Stamp bit.ly/47JPK8N
Linked Comment by @profbeckyg.bsky.social & Lisa K Stamp bit.ly/47JPK8N
NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky
September 11, 2025 at 3:47 PM
NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky
NEW COMMENT—Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease bit.ly/46xopoY #Medsky #Rheumsky
September 10, 2025 at 4:21 PM
NEW COMMENT—Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease bit.ly/46xopoY #Medsky #Rheumsky
Biomarkers for juvenile idiopathic arthritis treatment response—have we identified them?
Linked Comment by Stephanie KA Wong & Marinka Twilt bit.ly/42o1j1D
Linked Comment by Stephanie KA Wong & Marinka Twilt bit.ly/42o1j1D
September 9, 2025 at 2:48 PM
Biomarkers for juvenile idiopathic arthritis treatment response—have we identified them?
Linked Comment by Stephanie KA Wong & Marinka Twilt bit.ly/42o1j1D
Linked Comment by Stephanie KA Wong & Marinka Twilt bit.ly/42o1j1D
NEW RESEARCH—Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial bit.ly/4nrPIqK #JIA #Medsky #Rheumsky
September 9, 2025 at 2:47 PM
NEW RESEARCH—Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial bit.ly/4nrPIqK #JIA #Medsky #Rheumsky
Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention
Valentine Ribier and colleagues characterise the infectious burden of VEXAS syndrome and propose preventive strategies bit.ly/3VDJIPq
@terrierben.bsky.social
@sophiegeorgin.bsky.social
Valentine Ribier and colleagues characterise the infectious burden of VEXAS syndrome and propose preventive strategies bit.ly/3VDJIPq
@terrierben.bsky.social
@sophiegeorgin.bsky.social
September 5, 2025 at 9:47 AM
Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention
Valentine Ribier and colleagues characterise the infectious burden of VEXAS syndrome and propose preventive strategies bit.ly/3VDJIPq
@terrierben.bsky.social
@sophiegeorgin.bsky.social
Valentine Ribier and colleagues characterise the infectious burden of VEXAS syndrome and propose preventive strategies bit.ly/3VDJIPq
@terrierben.bsky.social
@sophiegeorgin.bsky.social
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms
Arvind Kaul and colleagues explores the links between VEXAS syndrome and rheumatic diseases, offering guidance on current management strategies bit.ly/4nkqhY4
@helenlachmann.bsky.social
Arvind Kaul and colleagues explores the links between VEXAS syndrome and rheumatic diseases, offering guidance on current management strategies bit.ly/4nkqhY4
@helenlachmann.bsky.social
September 5, 2025 at 9:45 AM
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms
Arvind Kaul and colleagues explores the links between VEXAS syndrome and rheumatic diseases, offering guidance on current management strategies bit.ly/4nkqhY4
@helenlachmann.bsky.social
Arvind Kaul and colleagues explores the links between VEXAS syndrome and rheumatic diseases, offering guidance on current management strategies bit.ly/4nkqhY4
@helenlachmann.bsky.social